Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial
- PMID: 29282046
- PMCID: PMC5745724
- DOI: 10.1186/s12906-017-2067-7
Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial
Abstract
Background: Cinnamon is considered as a treatment for many ailments in native medicine. Evidence suggests that Cinnamomum zeylanicum (CZ) has anti-microbial, anti-parasitic, anti-oxidant, blood glucose lowering properties and beneficial cardiovascular effects. The present study aims to evaluate Pharmacodynamic properties and safety of CZ in healthy adults using a Phase I Clinical Trial.
Methods: This phase I clinical trial was conducted at the Department of Pharmacology, Faculty of Medicine, University of Colombo, Sri Lanka. Thirty healthy adults were recruited for the study, conducted for a period of 3 months, with the dose of CZ (water extract) increased at monthly intervals (85 mg, 250 mg and 500 mg). Data collection was carried out at baseline and during each monthly follow up visit. Anthropometric, clinical and biochemical assessments were done at baseline and during follow up. Adverse effects and drug compliance was also evaluated.
Results: Twenty eight subjects completed the three months follow up. Mean age was 38.8 ± 10.4 years and 50% were males. There were no significant changes in the anthropometric parameters during the three months follow up. Both systolic and diastolic blood pressure reduced significant during the 1st month and this reduction was sustained throughout follow up. Full blood count, renal function tests, liver function tests, fasting blood glucose, HDL-c, VLDL-d and triglycerides remained within the normal range without any significant alteration during the 3 months. A significant reduction in the TC (p < 0.05) and LDL-c (p < 0.001) was noted at the end of the 3 months follow up period. There were no serious adverse effects (including hypersensitivity) noted. In two participants dyspepsia necessitated the discontinuation of study participation. Drug compliance was between 85 and 95% during the study period.
Conclusions: This is the first phase I clinical trial in health adults evaluating efficacy and safety of CZ. Our results demonstrate no significant side effects and toxicity of CZ, including hepatotoxicity and anti-coagulation properties. CZ demonstrated beneficial anti-hyperlipidaemic and blood pressure lowering effects among healthy adults. Further studies with larger samples and longer durations may be able to elucidate other side effects and better describe the pharmacodynamic properties.
Trial registration: SLCTR/2013/001 (Sri Lanka Clinical Trials Registry: http://www.slctr.lk/trials/106 ) (Date of Registration: 01/01/2013).
Keywords: Adults; Adverse effects; Ceylon cinnamon; Cinnamomum zeylanicum; Efficacy; Pharmacodynamic; Safety; Sri Lanka.
Conflict of interest statement
Ethics approval and consent to participate
Informed written consent was obtained from all participants. The study was approved by the Ethics Review Committee, Faculty of Medicine, University of Colombo, Sri Lanka (EC/12/157).
Consent for publication
Not applicable
Competing interests
The author(s) declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.Trials. 2017 Sep 29;18(1):446. doi: 10.1186/s13063-017-2192-0. Trials. 2017. PMID: 28962661 Free PMC article. Clinical Trial.
-
Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.BMC Complement Altern Med. 2013 Oct 22;13:275. doi: 10.1186/1472-6882-13-275. BMC Complement Altern Med. 2013. PMID: 24148965 Free PMC article. Review.
-
Phytochemical characterization and biological activity evaluation of ethanolic extract of Cinnamomum zeylanicum.J Ethnopharmacol. 2018 Jun 12;219:110-116. doi: 10.1016/j.jep.2018.02.001. Epub 2018 Mar 22. J Ethnopharmacol. 2018. PMID: 29408310
-
Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.Trials. 2017 Mar 14;18(1):124. doi: 10.1186/s13063-017-1863-1. Trials. 2017. PMID: 28292320 Free PMC article. Clinical Trial.
-
Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.Diabet Med. 2012 Dec;29(12):1480-92. doi: 10.1111/j.1464-5491.2012.03718.x. Diabet Med. 2012. PMID: 22671971 Review.
Cited by
-
Evaluation of clinical trials of ethnomedicine used for the treatment of diabetes: A systematic review.Front Pharmacol. 2023 Apr 7;14:1176618. doi: 10.3389/fphar.2023.1176618. eCollection 2023. Front Pharmacol. 2023. PMID: 37089934 Free PMC article.
-
Cinnamon: an aromatic condiment applicable to chronic kidney disease.Kidney Res Clin Pract. 2023 Jan;42(1):4-26. doi: 10.23876/j.krcp.22.111. Epub 2023 Jan 31. Kidney Res Clin Pract. 2023. PMID: 36747357 Free PMC article.
-
Plant-Derived Natural Products as Lead Agents against Common Respiratory Diseases.Molecules. 2022 May 10;27(10):3054. doi: 10.3390/molecules27103054. Molecules. 2022. PMID: 35630531 Free PMC article. Review.
-
Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development.Front Endocrinol (Lausanne). 2022 Feb 24;13:800714. doi: 10.3389/fendo.2022.800714. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282429 Free PMC article. Review.
-
Proanthocyanidins and Where to Find Them: A Meta-Analytic Approach to Investigate Their Chemistry, Biosynthesis, Distribution, and Effect on Human Health.Antioxidants (Basel). 2021 Jul 30;10(8):1229. doi: 10.3390/antiox10081229. Antioxidants (Basel). 2021. PMID: 34439477 Free PMC article. Review.
References
-
- Soliman MM, Attia HF, El-Shazly SA, Saleh OM. Biomedical effects of cinnamon extract on obesity and diabetes relevance in Wistar rats. American J Biochem Mol Biol. 2012;2:133–145. doi: 10.3923/ajbmb.2012.133.145. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources